Diagnosis: How to Read Your Pathology and Lab Reports
Last updated:
Diagnosing GSD IV and APBD requires a combination of genetic testing for GBE1 mutations, enzyme activity assays, and often tissue biopsies. Biopsies typically reveal abnormal glycogen clumps described as PAS-positive and diastase-resistant.
Key Takeaways
- • A complete GSD IV diagnosis typically includes genetic testing for GBE1 mutations, enzyme activity assays, and sometimes tissue biopsies or MRIs.
- • Pathologists look for PAS-positive, diastase-resistant inclusions in tissue biopsies, which indicate the presence of abnormal, unbreakable glycogen clumps.
- • The GBE1 assay measures glycogen branching enzyme function, with lower activity percentages generally indicating more severe forms of the disease.
- • Routine blood work may show elevated liver enzymes (AST/ALT) or muscle enzymes (CK), indicating the disease is stressing those organs.
- • Adults with APBD typically show specific damage to the brain's white matter and thinning of the cervical spinal cord on MRI scans.
Getting a diagnosis for Glycogen Storage Disease Type IV (GSD IV) often involves several different types of tests. Because the disease is so rare, the diagnostic report can be complex, combining genetic data, enzyme levels, and microscopic tissue analysis [1][2].
Understanding the “Pathology Language”
If you or your child had a tissue biopsy (usually of the liver, muscle, or skin), the pathologist’s report uses specific technical terms to describe the abnormal glycogen under the microscope.
“PAS-Positive, Diastase-Resistant Inclusions”
This is a hallmark diagnostic phrase for GSD IV [3][4].
- PAS-Positive: “PAS” (Periodic Acid-Schiff) is a special bright pink stain used to detect sugar (glycogen) in cells. If a sample is “PAS-positive,” it means sugar deposits are present [3].
- Diastase-Resistant: In a healthy cell, an enzyme called diastase easily dissolves and washes away normal glycogen. In GSD IV, however, the glycogen is tangled and knotted (polyglucosan). Because it is structurally abnormal, the diastase cannot break it down [5].
- Plain Language Meaning: The report is saying, “We found clumps of stored sugar that are so tough and abnormal that even our strongest laboratory enzymes couldn’t dissolve them.” [2][1].
Laboratory and Blood Tests
While no single routine blood test can diagnose GSD IV, certain markers help doctors see how organs are coping:
- Liver Enzymes (ALT and AST): These are often elevated if the disease is stressing the liver [6].
- Creatine Kinase (CK): This is a marker of muscle breakdown. It may be high if the disease is affecting the muscles [4].
- Chitotriosidase: This is an enzyme often found at very high levels in the blood of people with GSD IV and Adult Polyglucosan Body Disease (APBD), serving as an additional clue [7].
GBE1 Enzyme Activity Testing
This test measures how well your glycogen branching enzyme is actually working. It can be tested in skin cells (fibroblasts), liver tissue, or white blood cells [8][9].
- 0–5% Activity: Usually seen in the severe, early-onset forms [9].
- 5–20% Activity: Often seen in milder childhood forms or adult-onset APBD [9].
- Note: Because every lab uses slightly different testing methods, your results should always be compared to the lab’s specific “normal control” range [8].
Neuroimaging in Adults (APBD)
For adults with suspected APBD, an MRI of the brain and spine is a critical diagnostic tool [10]. Doctors look for two specific MRI “signatures”:
- Leukoencephalopathy: This shows up as bright white spots on the MRI, representing damage to the “white matter” (the brain’s internal wiring). These spots are often found around the brain’s fluid-filled spaces [11][12].
- Cervical Spinal Cord Atrophy: This means the spinal cord in the neck area appears thinner than usual, which explains the leg stiffness and walking difficulties [11][13].
Your Completeness Checklist
A “complete” diagnostic package for GSD IV should ideally include:
- [ ] Genetic Report: Identifying two mutations (pathogenic variants) in the GBE1 gene [1].
- [ ] Enzyme Assay: Documentation of reduced glycogen branching enzyme activity [14].
- [ ] Biopsy Report (if done): Specifically mentioning “PAS-positive, diastase-resistant” inclusions [3].
- [ ] Imaging Reports: For adults, MRI details regarding white matter and the spinal cord [10].
Frequently Asked Questions
What does 'PAS-positive, diastase-resistant' mean on my biopsy report?
What blood tests are used to help diagnose GSD IV?
What does the GBE1 enzyme activity test measure?
What do doctors look for on an MRI for Adult Polyglucosan Body Disease (APBD)?
Questions for Your Doctor
- • What was my precise GBE1 enzyme activity percentage, and what tissue was it measured in?
- • Do my MRI reports specifically mention 'leukoencephalopathy' or 'cervical spinal cord atrophy'?
- • Does my pathology report clearly state 'PAS-positive, diastase-resistant inclusions'?
- • Are my liver enzymes (AST/ALT) or muscle enzymes (CK) currently elevated?
- • Can you provide a copy of the full genetic testing report for my personal records?
Questions for You
- • If you had a biopsy, did the doctor fully explain what the pathologist saw under the microscope?
- • Have you noticed symptoms that correlate with your lab results (e.g., muscle weakness if your CK is high)?
- • Do you have your imaging (MRI) and biopsy reports organized in a binder or digital folder to share with new specialists?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Severe neuromuscular forms of glycogen storage disease type IV: Histological, clinical, biochemical, and molecular findings in a large French case series.
Lefèvre CR, Collardeau-Frachon S, Streichenberger N, et al.
Journal of inherited metabolic disease 2024; (47(2)):255-269 doi:10.1002/jimd.12692.
PMID: 38012812 - 2
Update on polyglucosan storage diseases.
Cenacchi G, Papa V, Costa R, et al.
Virchows Archiv : an international journal of pathology 2019; (475(6)):671-686 doi:10.1007/s00428-019-02633-6.
PMID: 31363843 - 3
Two cases of a non-progressive hepatic form of glycogen storage disease type IV with atypical liver pathology.
Ichimoto K, Fujisawa T, Shimura M, et al.
Molecular genetics and metabolism reports 2020; (24()):100601 doi:10.1016/j.ymgmr.2020.100601.
PMID: 32455116 - 4
Case of Neonatal Fatality from Neuromuscular Variant of Glycogen Storage Disease Type IV.
Sandhu T, Polan M, Yu Z, et al.
JIMD reports 2019; (45()):51-55 doi:10.1007/8904_2018_142.
PMID: 30311141 - 5
Intrasarcoplasmic Polyglucosan Inclusions in Heart and Skeletal Muscles of Long-Finned Pilot Whales (Globicephala melas) may be Age-Related.
Longué CM, Dagleish MP, McGovern G, et al.
Journal of comparative pathology 2020; (181()):18-25 doi:10.1016/j.jcpa.2020.09.011.
PMID: 33288146 - 6
Liver Transplantation for Glycogen Storage Disease Type IV.
Liu M, Sun LY
Frontiers in pediatrics 2021; (9()):633822 doi:10.3389/fped.2021.633822.
PMID: 33681109 - 7
A Broad Characterization of Glycogen Storage Disease IV Patients: A Clinical, Genetic, and Histopathological Study.
Wilke MVMB, de Oliveira BM, Starosta RT, et al.
Biomedicines 2023; (11(2)) doi:10.3390/biomedicines11020363.
PMID: 36830903 - 8
Analysis of GBE1 mutations via protein expression studies in glycogen storage disease type IV: A report on a non-progressive form with a literature review.
Iijima H, Iwano R, Tanaka Y, et al.
Molecular genetics and metabolism reports 2018; (17()):31-37 doi:10.1016/j.ymgmr.2018.09.001.
PMID: 30228975 - 9
A novel mouse model that recapitulates adult-onset glycogenosis type 4.
Orhan Akman H, Emmanuele V, Kurt YG, et al.
Human molecular genetics 2015; (24(23)):6801-10 doi:10.1093/hmg/ddv385.
PMID: 26385640 - 10
Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource.
Koch RL, Soler-Alfonso C, Kiely BT, et al.
Molecular genetics and metabolism 2023; (138(3)):107525 doi:10.1016/j.ymgme.2023.107525.
PMID: 36796138 - 11
Adult polyglucosan body disease: an acute presentation leading to unmasking of this rare disorder.
Johal J, Castro Apolo R, Johnson MW, et al.
Hospital practice (1995) 2022; (50(3)):244-250 doi:10.1080/21548331.2021.1874182.
PMID: 33412965 - 12
Frequent misdiagnosis of adult polyglucosan body disease.
Hellmann MA, Kakhlon O, Landau EH, et al.
Journal of neurology 2015; (262(10)):2346-51 doi:10.1007/s00415-015-7859-4.
PMID: 26194201 - 13
Adult polyglucosan body disease: ultrarare but commonly misdiagnosed.
Caiza-Zambrano F, Aldecoa M, Rugilo C, et al.
Practical neurology 2025; (25(4)):366-369 doi:10.1136/pn-2024-004429.
PMID: 39939164 - 14
A novel GBE1 gene variant in a child with glycogen storage disease type IV.
Said SM, Murphree MI, Mounajjed T, et al.
Human pathology 2016; (54()):152-6.
PMID: 27107456
This guide explains GSD IV and APBD diagnostic terminology for educational purposes only. Always consult your neurologist, genetic counselor, or primary physician to interpret your specific laboratory, imaging, and pathology reports.
Stay up to date
Get notified when new research about Glycogen Storage Disease Type IV is published.
No spam. Unsubscribe anytime.